Latest news
Should Biogen’s Profit Squeeze Amid Rising New-Therapy Sales Prompt Action From Biogen (BIIB) Investors? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 04:03:26 GMTWhy Biogen (BIIB) Is Up 5.8% After Q2 Revenue Beat And Raised 2026 Guidance - And What's Next - simplywall.stsimplywall.st · Thu, 30 Jul 2026 07:00:00 GMTBiogen's Q2 Earnings Beat, New Drugs Drive Sales, 2026 Guidance Raised - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTBiogen: The Turnaround Is Real Enough To Buy (Rating Upgrade) (NASDAQ:BIIB) - Seeking AlphaSeeking Alpha · Wed, 29 Jul 2026 07:00:00 GMTBiogen Q2 2026 Earnings Preview — July 29, Street Expects $2.10 EPS - AlphaStreetAlphaStreet · Mon, 27 Jul 2026 21:50:36 GMT